Research Article
[Retracted] A Meta-analysis of Xiaoyin Granules Combined with Acitretin Capsule in the Treatment of Psoriasis Vulgaris
Table 1
Characteristics of studies included.
| | First author | Year | Sample size (M/F) | Average age | T (M/F) | C (M/F) | Therapy | Duration (month) | Outcomes | | T | C | Effect | PASI score | Inflammatory factors |
| | SM Yang [13] | 2020 | 156 (89/67) | 39.2 | 78 (44/34) | 78 (45/33) | Aci+Xiaoyin | Aci | 2 | Y | N | N | | JW Guo [14] | 2019 | 97 (57/40) | 36.8 | 50 (30/20) | 47 (27/20) | Aci+Xiaoyin | Aci | 3 | Y | N | Y (IL-10, IL-17) | | P Liu [15] | 2019 | 75 (39/36) | 40.3 | 38 | 37 | Aci+Xiaoyin | Aci | 2 | Y | N | Y (IL-10, IL-17) | | LL Wang [16] | 2019 | 86 (44/42) | 51.9 | 43 (23/20) | 43 (21/22) | Aci+Xiaoyin | Aci | 2 | N | Y | N | | LN Ma [17] | 2018 | 79 (44/35) | 37.7 | 42 (23/19) | 37 (21/16) | Aci+Xiaoyin | Aci | 2 | Y | N | N | | F Hou [18] | 2018 | 80 | 38.7 | 40 (23/17) | 40 | Aci+Xiaoyin | Aci | 2 | N | Y | Y (IFN-γ, IL-4, IL-17) | | NL Shao [19] | 2018 | 98 (51/47) | 35.6 | 49 (25/24) | 49 (26/23) | Aci+Xiaoyin | Aci | 4 | Y | N | Y (IL-17) | | KK Han [20] | 2017 | 88 (51/37) | 35.7 | 44 (25/19) | 44 (26/18) | Aci+Xiaoyin | Aci | 3 | Y | N | Y (IL-10, IL-17) | | LY Yang [21] | 2017 | 80 (47/33) | 31.6 | 40 (24/16) | 40 (23/17) | Aci+Xiaoyin | Aci | 3 | Y | Y | Y (TNF-α, IL-17, IL-23) | | CQ Sun [22] | 2017 | 1000 | 45.0 | 500 | 500 | Aci+Xiaoyin | Xiaoyin | 2 | Y | N | N | | WE Wu [23] | 2016 | 140 (83/57) | 38.8 | 70 (43/27) | 70 (40/30) | Aci+Xiaoyin | Aci | 2 | Y | N | N | | HQ Wang [24] | 2016 | 50 (31/19) | 36.5 | 25 (16/9) | 25 (15/10) | Aci+Xiaoyin | Aci | 4 | Y | N | N | | D Liu [25] | 2015 | 214 (120/94) | 42.3 | 120 (70/50) | 94 (50/44) | Aci+Xiaoyin | Aci | 2 | Y | N | N | | J Ding [26] | 2015 | 200 (132/68) | 33.0 | 100 (69/31) | 100 (63/37) | Aci+Xiaoyin | Aci | 3 | Y | N | N | | QY Du [27] | 2014 | 140 (90/50) | 39.3 | 70 (45/25) | 70 (45/25) | Aci+Xiaoyin | Aci | 3 | Y | N | N | | YW Zhang [28] | 2014 | 148 (80/68) | 36.0 | 74 | 74 | Aci+Xiaoyin | Aci | 3 | Y | Y | N | | ZH Liang [29] | 2013 | 158 (98/60) | 40.1 | 93 (61/32) | 65 (37/28) | Aci+Xiaoyin | Aci | 3 | Y | N | N | | XJ Song [30] | 2013 | 86 (51/35) | 34.5 | 43 (25/18) | 43 (26/17) | Aci+Xiaoyin | Aci | 3 | Y | N | N | | LH Zhou [31] | 2012 | 140 (90/50) | 36.0 | 70 (46/24) | 70 (44/26) | Aci+Xiaoyin | Aci | 2 | Y | N | N | | SH Song [32] | 2011 | 98 (45/53) | 35.6 | 60 | 38 | Aci+Xiaoyin | Aci | 2 | Y | N | N | | JG Xiang [33] | 2008 | 68 (36/32) | 34.5 | 38 | 30 | Aci+Xiaoyin | Xiaoyin | 4 | Y | N | N | | PR Chen [34] | 2008 | 80 (45/35) | 26.5 | 24 | 26, 30 | Aci+Xiaoyin | Aci, Xiaoyin | 2 | Y | N | N | | B Chen [35] | 2007 | 222 (139/83) | 33.0 | 74 | 74, 74 | Aci+Xiaoyin | Aci, Xiaoyin | 4 | Y | N | N | | XJ Gong [36] | 2006 | 150 (84/66) | 34.7 | 60 (33/27) | 46 (26/20), 44 (25/19) | Aci+Xiaoyin | Aci, Xiaoyin | 3 | Y | N | N | | YX Li [37] | 2005 | 64 (52/12) | 30.4 | 32 (26/6) | 16 (14/2), 16 (12/4) | Aci+Xiaoyin | Aci, Xiaoyin | 3 | Y | N | N | | CL Xie [38] | 2016 | 104 (46/58) | 41.6 | 52 (22/30) | 52 (24/28) | Aci+Xiaoyin | Aci | 1 | Y | Y | Y (IL-10, IL-17) | | YQ Zhou [39] | 2012 | 120 (49/71) | 36.9 | 60 | 60 | Aci+Xiaoyin | Aci | 3 | Y | Y | N | | JS Lou [40] | 2007 | 110 (71/39) | 34.0 | 38 (26/12) | 36 (20/16), 36 (25/11) | Aci+Xiaoyin | Aci, Xiaoyin | 2 | Y | N | N |
|
|
